Lechi Ye

1.9k total citations · 1 hit paper
48 papers, 1.4k citations indexed

About

Lechi Ye is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lechi Ye has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Lechi Ye's work include Colorectal Cancer Treatments and Studies (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Cancer-related molecular mechanisms research (6 papers). Lechi Ye is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Cancer-related molecular mechanisms research (6 papers). Lechi Ye collaborates with scholars based in China, United States and Spain. Lechi Ye's co-authors include Ye Wei, Jianmin Xu, Dexiang Zhu, Li Ren, Xinyu Qin, Qing‐Hai Ye, Juji Dai, Tianshu Liu, Wei Cen and Junjun Qiu and has published in prestigious journals such as Science, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Lechi Ye

46 papers receiving 1.4k citations

Hit Papers

Cetuximab promotes RSL3-induced ferroptosis by suppressin... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
    2021 225 citations Juji Dai, Wei Cen et al. Cell Death and Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lechi Ye China 18 628 589 511 396 354 48 1.4k
Luca Faloppi Italy 25 807 1.3× 580 1.0× 601 1.2× 499 1.3× 457 1.3× 92 1.8k
Xinsen Xu China 20 469 0.7× 427 0.7× 300 0.6× 305 0.8× 256 0.7× 46 1.3k
Giorgia Marisi Italy 23 478 0.8× 603 1.0× 616 1.2× 233 0.6× 423 1.2× 71 1.4k
Ao Huang China 21 574 0.9× 725 1.2× 787 1.5× 479 1.2× 572 1.6× 51 1.9k
Yoshikuni Inokawa Japan 18 559 0.9× 453 0.8× 271 0.5× 364 0.9× 122 0.3× 81 1.2k
Lone H. Ottesen United States 18 618 1.0× 646 1.1× 214 0.4× 698 1.8× 237 0.7× 56 1.4k
Cheol-Keun Park South Korea 23 371 0.6× 682 1.2× 441 0.9× 200 0.5× 293 0.8× 48 1.3k
Manuel Valladares‐Ayerbes Spain 20 685 1.1× 672 1.1× 469 0.9× 359 0.9× 119 0.3× 74 1.4k
Enxiao Li China 17 671 1.1× 340 0.6× 213 0.4× 334 0.8× 302 0.9× 45 1.2k
Laura W. Goff United States 21 1.0k 1.6× 742 1.3× 326 0.6× 432 1.1× 347 1.0× 77 2.0k

Countries citing papers authored by Lechi Ye

Since Specialization
Citations

This map shows the geographic impact of Lechi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lechi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lechi Ye more than expected).

Fields of papers citing papers by Lechi Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lechi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lechi Ye. The network helps show where Lechi Ye may publish in the future.

Co-authorship network of co-authors of Lechi Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Lechi Ye. A scholar is included among the top collaborators of Lechi Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lechi Ye. Lechi Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Shuang, Meng Li, Jinxin Zhang, et al.. (2025). A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis. Science. 388(6746). eadp5540–eadp5540. 4 indexed citations
2.
Cen, Wei, Feifan Guo, Xialin Yan, et al.. (2024). An internally and externally validated nomogram for predicting cancer-specific survival in octogenarians after radical resection for colorectal cancer. Aging Clinical and Experimental Research. 36(1). 152–152. 1 indexed citations
3.
4.
Zhou, Bo, Zhuoyang Fan, Wei Zhang, et al.. (2024). SHP2 mutations promote glycolysis and inhibit apoptosis via PKM2/hnRNPK signaling in colorectal cancer. iScience. 27(8). 110462–110462. 4 indexed citations
5.
6.
7.
8.
Lv, Yang, Peng Zheng, Yihao Mao, et al.. (2023). Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer. Cancer Science. 115(1). 257–269. 7 indexed citations
9.
Li, Chichi, Jingye Pan, Lechi Ye, et al.. (2019). Autophagy regulates the therapeutic potential of adipose-derived stem cells in LPS-induced pulmonary microvascular barrier damage. Cell Death and Disease. 10(11). 804–804. 17 indexed citations
10.
Li, Chichi, et al.. (2017). Rapamycin Promotes the Survival and Adipogenesis of Ischemia-Challenged Adipose Derived Stem Cells by Improving Autophagy. Cellular Physiology and Biochemistry. 44(5). 1762–1774. 22 indexed citations
11.
Ye, Lechi, et al.. (2016). Liver resection of metastases for colorectal cancer, gastric cancer and breast cancer: two hospital experiences. Translational Cancer Research. 5(5). 562–569. 1 indexed citations
12.
Ye, Lechi, et al.. (2016). Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients. Clinica Chimica Acta. 473. 198–203. 10 indexed citations
13.
Zheng, Xiangtao, Ziheng Wu, Ye Wei, et al.. (2016). Induction of autophagy by salidroside through the AMPK-mTOR pathway protects vascular endothelial cells from oxidative stress-induced apoptosis. Molecular and Cellular Biochemistry. 425(1-2). 125–138. 60 indexed citations
14.
Chang, Wenju, Ye Wei, Li Ren, et al.. (2015). Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer. Annals of Surgery. 263(3). 434–439. 19 indexed citations
15.
Ye, Lechi, Li Ren, Junjun Qiu, et al.. (2015). Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. Tumor Biology. 36(11). 8747–8754. 32 indexed citations
16.
Ye, Lechi, Ouchen Wang, Guanli Huang, et al.. (2015). IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population. OncoTargets and Therapy. 8. 1493–1493. 16 indexed citations
17.
Chen, Tao, Zhong Ren, Lechi Ye, et al.. (2015). Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway. Cancer Biology & Therapy. 16(2). 244–252. 34 indexed citations
18.
19.
Lin, Qi, Qing‐Hai Ye, Dexiang Zhu, et al.. (2014). Comparison of minimally invasive and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases: a propensity score analysis. International Journal of Colorectal Disease. 30(3). 385–395. 32 indexed citations
20.
Ye, Lechi, Tianshu Liu, Li Ren, et al.. (2013). Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases. Journal of Clinical Oncology. 31(16). 1931–1938. 296 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Faloppi Breakdown of academic impact, for papers by Xinsen Xu Breakdown of academic impact, for papers by Giorgia Marisi Breakdown of academic impact, for papers by Ao Huang Breakdown of academic impact, for papers by Yoshikuni Inokawa Breakdown of academic impact, for papers by Lone H. Ottesen Breakdown of academic impact, for papers by Cheol-Keun Park Breakdown of academic impact, for papers by Manuel Valladares‐Ayerbes Breakdown of academic impact, for papers by Enxiao Li Breakdown of academic impact, for papers by Laura W. Goff
Rankless by CCL
2026